OASIS® Wound Matrix is a natural extracellular matrix derived from a single layer of porcine small intestinal submucosa (SIS) technology. The technology provides an intact three-dimensional extracellular matrix which allows for host cell migration. Storage at room temperature with a shelf-life of two years.
• Proven management of a wide array of acute and chronic wounds
• Comes ready to apply
• Easy to trim to size and shape of wound
• Minimally processed and sterilized
• Can be used in a variety of settings, including long-term, outpatient and at-home care
• Long-term storage without compromising ability to support healing
• Naturally derived structure that supports healing process
• Incorporated and absorbed into the wound
• Contains components similar to those found in the human dermis
OASIS® Wound Matrix is indicated for the management of wounds including partial- and full-thickness wounds, pressure ulcers, venous ulcers, chronic vascular ulcers, tunneling and undermining wounds, diabetic ulcers, trauma wounds (abrasions, lacerations, second-degree burns, skin tears), draining wounds and surgical wounds (donor sites/grafts, post-Mohs surgery, post-laser surgery, podiatric, wound dehiscence).
This device is derived from a porcine source and should not be used in patients with known sensitivity to porcine material. This device is not indicated for use on third-degree burns.
Do not re-sterilize. Discard all open and unused portions of OASIS® Wound Matrix.
Device is sterile if the package is dry, unopened and undamaged. Do not use if the package seal is broken.
The device must be used prior to the expiration date.
Discard device if mishandling has caused possible damage or contamination.
OASIS® Wound Matrix should not be applied until excessive exudate, bleeding, acute swelling and infection are controlled.
The following complications are possible. If any of these conditions occur, the device should be removed:
Chronic inflammation (Initial application of wound dressings may be associated with transient, mild, localized inflammation.)
Excessive redness, pain, swelling or blistering
This device should be stored in a clean, dry location at room temperature.
|Assigned HCPCS code||●|
|Shelf life greater than 2 years|
|Shelf life limited|
|Indicated for acute wounds||●|
|Indicated for chronic wounds||●|
|Indicated for diabetic ulcers||●|
|Indicated for pressure ulcers||●|
|Indicated for second-degree burns||●|
|Indicated for surgical wounds||●|
|Indicated for third-degree burns|
|Indicated for venous ulcers||●|
|Contact manufacturer for usage guidelines|
|Educational Material Available||●|
|Free Samples/Trials Available||●|
|Published Clinical Article Available||●|
Chronic Vascular Ulcers
Partial- and Full-Thickness Wounds
Surgical Wounds (Donor Sites/Grafts, Post-Mohs Surgery, Post-Laser Surgery, Podiatric, Wound Dehiscence)
Tunneled or Undermined Wounds
Trauma Wounds (Abrasions, Lacerations, Second-Degree Burns, Skin Tears)
Prepare the wound bed to make it free of exudate and devitalized tissue. Wait for any bleeding to stop before applying OASIS® Wound Matrix.
Measure the wound and select the appropriately sized sheet of dry OASIS® Wound Matrix. Cut the sheet to size and position it to cover the wound surface, extending slightly beyond all wound margins. If multiple sheets are necessary, overlap the edges slightly. As required, anchor OASIS® Wound Matrix using the physician's preferred fixation method.
Thoroughly rehydrate OASIS® Wound Matrix by applying sterile saline.
Apply a non-adherent primary wound dressing over OASIS® Wound Matrix.
Select an appropriate secondary dressing that will manage the wound exudate, keep the OASIS® Wound Matrix moist and keep all layers securely in place.
Only change the primary dressing as necessary, typically every seven days, and change the secondary dressing as appropriate. Carefully remove any remaining loose product from around the wound edges as needed.
To avoid product disruption, only change the primary dressing as necessary, typically every seven days. If a gel forms on the wound surface, do not attempt to forcibly remove it. Gently rinse the wound surface, leaving the extracellular matrix (ECM) gel intact. Reapplication is typically necessary every seven days. Reapply as needed if the OASIS® Wound Matrix is no longer covering the wound and wound is free of infection and necrosis, but not fully epithelialized.
Apply a non-adherent primary wound dressing over OASIS® Wound Matrix. Apply an appropriate secondary dressing (multilayer compression bandage system, total contact cast or other appropriate dressing) that will manage the wound exudate, keep the OASIS® Wound Matrix moist and keep all layers securely in place.
Porcine small intestinal submucosa that provides a single layer of fenestrated naturally derived ECM. OASIS® Wound Matrix is supplied sterile in peel-open packages and is intended for one-time use.
For over 150 years, Smith+Nephew has taken a pioneering approach to product design and services, helping to reduce the human and economic costs of wounds.
Advanced Wound Bioactives
(Includes Collagenase SANTYL* Ointment, PROSHIELD* Foam & Spray Incontinent & Total Body Cleanser, PROSHIELD* Plus Skin Protectant, REGRANEX* (becaplermin) Gel 0.01%)
Toll-free: (800) 441-8227
Fax: (817) 900-4100
Cellular and/or Tissue-Based Products
(Includes GRAFIX PL*, GRAFIX*, STRAVIX*, OASIS® MICRO, OASIS® Wound Matrix, OASIS® Burn Matrix, and OASIS® Ultra Tri-Layer Matrix)
Phone: (888) 674-9551
Fax: (443) 283-4419
Advanced Wound Care or Devices
(Includes all other products listed below)
Toll-free: (800) 876-1261
Fax: (727) 392-6914
*Trademark of Smith+Nephew